CA Stock MarketDetailed Quotes

FRX Fennec Pharmaceuticals Inc

Watchlist
  • 8.420
  • +0.180+2.18%
15min DelayMarket Closed Jun 28 16:00 ET
230.05MMarket Cap155.93P/E (TTM)

Fennec Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
1,413.24%25.38M
1,284.50%21.25M
534.20%9.74M
6.52M
3.33M
1.68M
1.54M
1.54M
0
0
Operating revenue
1,413.24%25.38M
1,284.50%21.25M
534.20%9.74M
--6.52M
--3.33M
--1.68M
--1.54M
--1.54M
--0
--0
Cost of revenue
478.95%550K
1,363.95%1.26M
696.51%685K
331K
148K
95K
86K
86K
0
0
Gross profit
1,469.34%24.83M
1,279.78%19.99M
524.57%9.05M
6.18M
3.18M
1.58M
1.45M
1.45M
0
0
Operating expense
60.37%11.1M
36.65%33.05M
42.91%10.94M
-8.67%7.27M
56.58%7.84M
94.88%6.92M
40.43%24.19M
81.93%7.65M
90.82%7.96M
27.78%5.01M
Selling and administrative expenses
61.81%11.08M
59.50%32.71M
45.12%10.84M
1.93%7.19M
102.04%7.84M
224.70%6.85M
67.51%20.51M
102.69%7.47M
140.63%7.05M
24.29%3.88M
-Selling and marketing expense
105.81%5.21M
335.30%12.12M
38.89%3.87M
--3.38M
--2.34M
--2.53M
--2.79M
--2.79M
--0
--0
-General and administrative expense
36.02%5.87M
16.16%20.59M
48.83%6.97M
-46.05%3.81M
41.70%5.5M
104.69%4.32M
44.76%17.72M
27.09%4.68M
140.63%7.05M
24.29%3.88M
Research and development costs
-25.00%3K
-98.41%56K
-72.65%32K
-98.58%12K
-99.29%8K
-99.72%4K
-29.11%3.53M
-77.63%117K
-31.88%846K
41.38%1.13M
Depreciation amortization depletion
-72.22%20K
92.62%287K
0.00%70K
12.50%72K
----
928.57%72K
--149K
--70K
--64K
----
-Depreciation and amortization
-72.22%20K
92.62%287K
0.00%70K
12.50%72K
----
928.57%72K
--149K
--70K
--64K
----
Operating profit
356.89%13.72M
42.57%-13.06M
69.57%-1.89M
86.32%-1.09M
6.85%-4.67M
-50.35%-5.34M
-32.02%-22.74M
-47.49%-6.21M
-90.82%-7.96M
-27.78%-5.01M
Net non-operating interest income (expenses)
-21.48%-837K
-277.14%-2.95M
-35.36%-800K
-693.68%-754K
-1,298.21%-783K
-1,306.12%-689K
-789.77%-783K
-936.84%-591K
-90.00%-95K
-1,966.67%-56K
Non-operating interest income
80.73%197K
126.15%441K
-24.84%115K
325.00%102K
1,177.78%115K
1,111.11%109K
261.11%195K
1,076.92%153K
84.62%24K
-25.00%9K
Non-operating interest expense
29.57%1.03M
247.03%3.39M
22.98%915K
619.33%856K
1,347.37%825K
1,275.86%798K
676.19%978K
1,100.00%744K
116.36%119K
533.33%57K
Total other finance cost
----
----
----
----
812.50%73K
----
----
----
----
--8K
Other net income (expenses)
-133.33%-49K
82.38%-34K
109.84%6K
22.58%-24K
171.43%5K
77.66%-21K
-451.43%-193K
62.58%-61K
-181.58%-31K
91.67%-7K
Gain on sale of security
-133.33%-49K
82.38%-34K
109.84%6K
22.58%-24K
171.43%5K
77.66%-21K
-451.43%-193K
62.58%-61K
-181.58%-31K
91.67%-7K
Income before tax
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
Income tax
Earnings from equity interest net of tax
Net income
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
Net income continuous operations
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
Noncontrolling interests
Net income attributable to the company
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
Diluted earnings per share
304.35%0.47
33.33%-0.6
60.00%-0.1
77.42%-0.07
-10.53%-0.21
-64.29%-0.23
-34.33%-0.9
-47.06%-0.25
-93.75%-0.31
-26.67%-0.19
Basic earnings per share
278.26%0.41
33.33%-0.6
60.00%-0.1
77.42%-0.07
-10.53%-0.21
-64.29%-0.23
-34.33%-0.9
-47.06%-0.25
-93.75%-0.31
-26.67%-0.19
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 1,413.24%25.38M1,284.50%21.25M534.20%9.74M6.52M3.33M1.68M1.54M1.54M00
Operating revenue 1,413.24%25.38M1,284.50%21.25M534.20%9.74M--6.52M--3.33M--1.68M--1.54M--1.54M--0--0
Cost of revenue 478.95%550K1,363.95%1.26M696.51%685K331K148K95K86K86K00
Gross profit 1,469.34%24.83M1,279.78%19.99M524.57%9.05M6.18M3.18M1.58M1.45M1.45M00
Operating expense 60.37%11.1M36.65%33.05M42.91%10.94M-8.67%7.27M56.58%7.84M94.88%6.92M40.43%24.19M81.93%7.65M90.82%7.96M27.78%5.01M
Selling and administrative expenses 61.81%11.08M59.50%32.71M45.12%10.84M1.93%7.19M102.04%7.84M224.70%6.85M67.51%20.51M102.69%7.47M140.63%7.05M24.29%3.88M
-Selling and marketing expense 105.81%5.21M335.30%12.12M38.89%3.87M--3.38M--2.34M--2.53M--2.79M--2.79M--0--0
-General and administrative expense 36.02%5.87M16.16%20.59M48.83%6.97M-46.05%3.81M41.70%5.5M104.69%4.32M44.76%17.72M27.09%4.68M140.63%7.05M24.29%3.88M
Research and development costs -25.00%3K-98.41%56K-72.65%32K-98.58%12K-99.29%8K-99.72%4K-29.11%3.53M-77.63%117K-31.88%846K41.38%1.13M
Depreciation amortization depletion -72.22%20K92.62%287K0.00%70K12.50%72K----928.57%72K--149K--70K--64K----
-Depreciation and amortization -72.22%20K92.62%287K0.00%70K12.50%72K----928.57%72K--149K--70K--64K----
Operating profit 356.89%13.72M42.57%-13.06M69.57%-1.89M86.32%-1.09M6.85%-4.67M-50.35%-5.34M-32.02%-22.74M-47.49%-6.21M-90.82%-7.96M-27.78%-5.01M
Net non-operating interest income (expenses) -21.48%-837K-277.14%-2.95M-35.36%-800K-693.68%-754K-1,298.21%-783K-1,306.12%-689K-789.77%-783K-936.84%-591K-90.00%-95K-1,966.67%-56K
Non-operating interest income 80.73%197K126.15%441K-24.84%115K325.00%102K1,177.78%115K1,111.11%109K261.11%195K1,076.92%153K84.62%24K-25.00%9K
Non-operating interest expense 29.57%1.03M247.03%3.39M22.98%915K619.33%856K1,347.37%825K1,275.86%798K676.19%978K1,100.00%744K116.36%119K533.33%57K
Total other finance cost ----------------812.50%73K------------------8K
Other net income (expenses) -133.33%-49K82.38%-34K109.84%6K22.58%-24K171.43%5K77.66%-21K-451.43%-193K62.58%-61K-181.58%-31K91.67%-7K
Gain on sale of security -133.33%-49K82.38%-34K109.84%6K22.58%-24K171.43%5K77.66%-21K-451.43%-193K62.58%-61K-181.58%-31K91.67%-7K
Income before tax 312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M-93.29%-8.09M-26.77%-5.07M
Income tax
Earnings from equity interest net of tax
Net income 312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M-93.29%-8.09M-26.77%-5.07M
Net income continuous operations 312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M-93.29%-8.09M-26.77%-5.07M
Noncontrolling interests
Net income attributable to the company 312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M-93.29%-8.09M-26.77%-5.07M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M-93.29%-8.09M-26.77%-5.07M
Diluted earnings per share 304.35%0.4733.33%-0.660.00%-0.177.42%-0.07-10.53%-0.21-64.29%-0.23-34.33%-0.9-47.06%-0.25-93.75%-0.31-26.67%-0.19
Basic earnings per share 278.26%0.4133.33%-0.660.00%-0.177.42%-0.07-10.53%-0.21-64.29%-0.23-34.33%-0.9-47.06%-0.25-93.75%-0.31-26.67%-0.19
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg